Clearmind Medicine Inc. (CMND) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Vancouver, BC, 캐나다. 현재 CEO는 Adi Zuloff-Shani.
CMND 을(를) 보유 IPO 날짜 2022-11-15, 4 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $88.83K.
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
